Compared to subjects with benign endometrial changes (polyps and myoma), SOD activity was significantly decreased in patients with hyperplasia simplex (41%, p < 0.05), hyperplasia complex (53%, p < 0.05) and adenocarcinoma (72%, p < 0.05) patients. The gene discussed is SOD1; the disease is hyperplasia.